(Total Views: 1091)
Posted On: 09/01/2022 3:20:44 PM
Post# of 153940
From YMB
“Barring unforeseen announcements, the next item on known timeline is estimated mntbc study completion date of September 16th. GLTA Longs and Go Leronlimab. We currently have 9 months of additional data for OS and PFS vs SOC as requested by the FDA last December in response to our last BTD filing.”
“Barring unforeseen announcements, the next item on known timeline is estimated mntbc study completion date of September 16th. GLTA Longs and Go Leronlimab. We currently have 9 months of additional data for OS and PFS vs SOC as requested by the FDA last December in response to our last BTD filing.”
(5)
(0)
